|
|||||
|
|
Therapy for Pulmonary Arterial Hypertension in Adults: Update of the CHEST Guideline and Expert Panel Report |
|
| Authors: | James R. Klinger C. Gregory Elliott Deborah J. Levine Eduardo Bossone Laura Duvall Karen Fagan Julie Frantsve-Hawley Steven M. Kawut John J. Ryan Erika B. Rosenzweig Nneka Sederstrom Virginia D. Steen David B. Badesch |
| Affiliation: | 1. Brown University, Providence, RI;2. Intermountain Healthcare and the University of Utah School of Medicine, Murray, UT;3. University of Texas Health Science Center at San Antonio, San Antonio, TX;4. A. Cardarelli Hospital, Naples, Italy;5. OhioHealth/The Ohio State University, Columbus, OH;6. University of South Alabama, Mobile, AL;7. CHEST, Glenview, IL;8. Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA;9. University of Utah, Salt Lake City, UT;10. Columbia University Medical Center, New York, NY;11. Children’s Hospitals and Clinics of Minnesota, Minneapolis, MN;12. Georgetown University Medical Center, Washington, DC;13. University of Colorado School of Medicine, Aurora, CO |
| Abstract: | |
| Keywords: | evidence-based medicine guidelines pulmonary arterial hypertension (PAH) 6MWD 6-min walk distance AHRQ Agency for Healthcare Research and Quality CHEST American College of Chest Physicians COI conflict of interest ERA endothelin receptor antagonist FC functional class FDA Food and Drug Administration GRADE Grading of Recommendations, Assessment, Development and Evaluation HR hazard ratio IPAH idiopathic pulmonary arterial hypertension MID minimally important difference PAH pulmonary arterial hypertension PDE5I phosphodiesterase type-5 inhibitor PH pulmonary hypertension PICO population, intervention, comparator, outcome SSc-PAH scleroderma-spectrum of disease and PAH SSRI selective serotonin reuptake inhibitor WHO World Health Organization |
| 本文献已被 ScienceDirect 等数据库收录！ | |